Bactolac Pharmaceutical
Bactolac Pharmaceutical is a privately held U.S. contract manufacturer of dietary supplements, operating a 650,000 sq. ft. cGMP facility in Hauppauge, NY, serving supplement brands, retailers, startups, and sports-nutrition clients with turnkey formulation, manufacturing, testing, packaging, and FBA fulfillment.
- Company typePrivate
- Founded1995
- HeadquartersHauppauge, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bactolac Pharmaceutical does
Bactolac Pharmaceutical, Inc. is a privately held U.S. contract manufacturer of dietary and nutritional supplements, founded in 1995 and headquartered in a 650,000 sq. ft. cGMP-certified facility in Hauppauge, New York. The company operates a turnkey B2B model that bundles formulation development, manufacturing, in-house analytical and microbiological testing, packaging, labeling, and direct Amazon FBA fulfillment for supplement brands, retailers, startups, and sports-nutrition customers. Production capabilities span tablets (including bi-layer, chewable, effervescent, enteric-coated, and time-release formats), capsules (soft gel, liquid-filled veggie, nanoparticle, delayed release), powders (collagen, hydration, electrolytes, greens), and specialized categories including nootropics, longevity, women's health, GLP-1 support, and pet supplements.
Revenue is generated through quote-based contract manufacturing and private-label agreements; minimum orders start at 2,500 bottles and scale upward, with free quotes returned within 48 hours. The company holds a dense stack of regulatory certifications — FDA cGMP, NSF GMP, NSF Certified for Sport, NPA GMP, UL, QAI Organic, USDA NOP, and Health Canada Foreign Site GMP — that materially qualify it for regulated, sports, organic, and cross-border Canadian sale channels. The business is independently operated with no disclosed parent or institutional investor, runs enterprise field sales with a Request-a-Quote funnel, and is led by a small public management team including a Director of R&D and an EVP of Business Development.
Bactolac Pharmaceutical firmographics
Firmographics- Name
- Bactolac Pharmaceutical
- Legal name
- Bactolac Pharmaceutical, Inc.
- Website
- https://bactolac.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Bactolac Pharmaceutical is a privately held U.S. contract manufacturer of dietary supplements, operating a 650,000 sq. ft. cGMP facility in Hauppauge, NY, serving supplement brands, retailers, startups, and sports-nutrition clients with turnkey formulation, manufacturing, testing, packaging, and FBA fulfillment.
- Ownership category
- akta.pro rank
Bactolac Pharmaceutical industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule API Commercial Manufacturing (HLAGAHAB)
- akta.pro secondary industries
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)
Keywords
Where Bactolac Pharmaceutical is headquartered
LocationHeadquarters
- HQ city
- Hauppauge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bactolac Pharmaceutical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Revenue model
- Contract Manufacturing Services: Bactolac generates revenue by providing full-service contract manufacturing for dietary supplements. Services include product development, formulation, manufacturing, testing, packaging, and label application. The company manufactures supplements in various formats including tablets, capsules, softgels, and powders for brands seeking to outsource production.
- Private Label Manufacturing: Revenue is generated through private label manufacturing where brands use Bactolac's formulations and production capabilities to bring supplements to market under their own brand names. The company provides turnkey solutions including formulation, manufacturing, and packaging.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Bactolac Pharmaceutical product offering
Product offeringCore offering
Based on the company name only, Bactolac Pharmaceutical appears to be a pharmaceutical manufacturing entity; however, no attributable source material was provided in the input to substantiate a detailed description of its core offerings.
Product overview
Bactolac Pharmaceutical is a turn-key dietary supplement contract manufacturer offering integrated production services from a single 650,000 sq. ft. cGMP-certified facility in Hauppauge, New York. The company provides comprehensive manufacturing across multiple dosage forms (tablets, capsules, powders, soft gels, liquids) and product categories including vitamins, nutritional supplements, herbal supplements, sports nutrition, pet products, and specialized formulations for nootropic/cognitive health, longevity/anti-aging, and women's health. Their service portfolio is structured as an integrated platform combining product development, manufacturing, in-house analytical testing, packaging/labeling, and distribution—enabling brands to access all capabilities under one roof. Key modules include capsule manufacturing (soft gel, liquid-filled hard veggie, nanoparticle, delayed release), tablet manufacturing (multiple coating and release technologies), powder manufacturing (collagen, hydration, electrolytes, greens), packaging services (bottles, blisters, stick packs, pouches), and analytical lab testing. The company also offers specialized capabilities for GLP-1 support solutions, super food products, and clean-label/sustainable formulations. Founded in 1995, Bactolac serves as a strategic manufacturing partner for brands seeking to scale from concept to market.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Over 30 years of manufacturing experience
- +2 more outcomes
Companies that use Bactolac Pharmaceutical
Customer profileSegments4 records
Ideal customer profiles1 record
Bactolac Pharmaceutical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Bactolac Pharmaceutical partnerships and signals
Strategic signalScale indicators3 records
Recent moves8 records
Expansion highlights5 records
Bactolac Pharmaceutical competitors and assessment
Company assessmentDirect peers
- Best Formulations: Best Formulations is a cGMP-certified supplement contract manufacturer offering full turnkey services including formulation, manufacturing, packaging, and testing across capsules, tablets, softgels, and powders. It directly competes with Bactolac for wellness and supplement brand customers.
- Vitakem: Vitakem is a dietary supplement contract manufacturer offering capsule, tablet, powder, and liquid supplement production with private label and custom formulation services. It directly competes with Bactolac in the nutraceutical CDMO market.
- CapsCanada: CapsCanada is a leading manufacturer of capsules (including gelatin, HPMC, and pullulan) supplying the supplement industry with both empty capsules and contract encapsulation services. It directly overlaps with Bactolac's capsule manufacturing line of business.
- Supplement Manufacturing Partner: Supplement Manufacturing Partner is a turnkey supplement CDMO providing formulation, manufacturing, packaging, and labeling for emerging and established supplement brands. It directly competes with Bactolac for outsourced supplement production.
- Robinson Pharma: Robinson Pharma is one of the largest U.S. contract manufacturers of dietary supplements, offering vitamins, minerals, herbal and sports nutrition products in tablets, capsules, softgels, and powders. It directly competes with Bactolac in the same CDMO space serving supplement brands.
- Makers Nutrition: Makers Nutrition is a full-service supplement contract manufacturer and private label provider with in-house formulation, manufacturing, packaging, and fulfillment capabilities. It competes head-to-head with Bactolac in turnkey supplement CDMO services for brands of all sizes.
- Pharma Tech Industries: Pharma Tech Industries is one of the largest U.S. contract manufacturers of powders and effervescent tablets for the dietary supplement industry, with turnkey manufacturing and packaging services. It directly overlaps with Bactolac's powder and tablet CDMO offerings.
Broad incumbents
- Lonza: Lonza is one of the world's largest CDMOs providing development and manufacturing services across pharma, biotech, and nutrition. Its nutrition and consumer health segment overlaps with Bactolac's contract manufacturing services but at significantly larger scale and broader geographic footprint.
- Catalent: Catalent is a global CDMO serving pharmaceutical and consumer health companies with softgel, oral solid, and biologics capabilities. It is a broader incumbent that overlaps with Bactolac's softgel and tablet manufacturing capabilities within a much wider portfolio.
- Aenova: Aenova is a global pharmaceutical and nutraceutical CDMO offering formulation development, manufacturing, and packaging across multiple dosage forms. It is a broader incumbent whose nutritional supplement business overlaps with Bactolac's CDMO offering but operates at a larger scale and geography.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Bactolac Pharmaceutical compliance and trust
Trust signalCompliance10 records
Bactolac Pharmaceutical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bactolac Pharmaceutical leadership team
Management profileNumber of profiles
Bactolac Pharmaceutical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bactolac Pharmaceutical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bactolac Pharmaceutical
What does Bactolac Pharmaceutical do?
Based on the company name only, Bactolac Pharmaceutical appears to be a pharmaceutical manufacturing entity; however, no attributable source material was provided in the input to substantiate a detailed description of its core offerings.
Is Bactolac Pharmaceutical a public or private company?
Bactolac Pharmaceutical is a private company. It is classified as unknown and is currently operating.
When was Bactolac Pharmaceutical founded?
Bactolac Pharmaceutical was founded in 1995. It employs 101 to 250 people.
Where is Bactolac Pharmaceutical based?
Bactolac Pharmaceutical is headquartered in Hauppauge, United States, in the North America region.
How does Bactolac Pharmaceutical make money?
Two revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are private Label Manufacturing.
Who are Bactolac Pharmaceutical's main competitors?
Direct peers on record are Best Formulations, Vitakem, CapsCanada, Supplement Manufacturing Partner, Robinson Pharma, Makers Nutrition and Pharma Tech Industries. Broad incumbents are Lonza, Catalent and Aenova.
Does Bactolac Pharmaceutical have an API?
No public API is recorded for Bactolac Pharmaceutical.
What industry is Bactolac Pharmaceutical in?
Bactolac Pharmaceutical's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 32541 and its SIC code is 2834.